How Is High Power (200w) Thulium Laser Vapoenucleation of the Prostate Impacting Functional Parameters? Short-Term Follow-Up Results
Abstract
Objective: To assess the efficacy and safety of thulium laser vapoenucleation of the prostate and its impact on patient’s lower urinary tract symptoms, erectile, and ejaculatory functions, we conducted the current prospective trial employing a high-power (200 W) Thulium: YAG laser system. Material and Methods: Between December 2021 and June 2022, we prospectively collected data on patients who underwent Thulium vapoenucleation of the prostate (ThuVEP) in our clinic to treat the signs and symptoms of benign prostatic hyperplasia. A sample size of 50 cases was obtained after applying exclusion criteria. In the first and sixth months following surgery, all patients were compared to their preoperative status in terms of lower urinary tract symptoms, erectile function, and ejaculatory symptoms. The Modified Clavien-Dindo Classification was also used to classify the complications that occurred. Results: The patients' IPSS scores showed a notable and significant improvement at the end of the 6-month follow-up. When compared to the preoperative state, erectile functions as measured by the IIEF-5 score did not significantly change with the surgery. At the end of the follow-up period, there was a substantial deterioration of ejaculatory functions as measured by the MSHQ-EjD score. During and after the procedure, complications at the Clavien 3a level were seen in 2 (4%) of the patients, but no complications above this level were seen. Conclusion: The ThuVEP method, used in the surgical…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.